Alexander Y Tokman insider trades: ENDRA Life Sciences (NDRA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alexander reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 23, 2022 | NDRA | ↑ Buy | 10,000 | $0.17 | $2K | Direct | Nov 28, 2022 (5d) |
| Aug 22, 2022 | NDRA | ↑ Buy | 20,000 | $0.26 | $5K | Direct | Aug 24, 2022 (2d) |
| May 16, 2022 | NDRA | ↑ Buy | 100,000 | $0.20 | $20K | Direct | May 17, 2022 (1d) |
| Jan 8, 2021 | NDRA | ↓ Sell | 10,000 | $0.90 | $9K | Direct | Jan 8, 2021 (0d) |
| Dec 14, 2016 | MVIS | ↑ Buy | 46,730 | $1.07 | $50K | Direct | Dec 14, 2016 (0d) |
| Nov 13, 2015 | MVIS | ↑ Buy | 10,000 | $2.33 | $23K | Direct | Nov 16, 2015 (3d) |
| Dec 5, 2013 | MVIS | ↑ Buy | 10,000 | $1.27 | $13K | Direct | Dec 5, 2013 (0d) |
| Nov 19, 2013 | MVIS | ↑ Buy | 20,000 | $1.35 | $27K | Direct | Nov 19, 2013 (0d) |
| Dec 9, 2011 | MVIS | ↑ Buy | 25,000 | $0.39 | $10K | Direct | Dec 12, 2011 (3d) |
| Nov 16, 2011 | MVIS | ↑ Buy | 15,000 | $0.47 | $7K | Direct | Nov 16, 2011 (0d) |
| Sep 8, 2011 | MVIS | ↑ Buy | 10,000 | $0.92 | $9K | Direct | Sep 8, 2011 (0d) |
| Aug 18, 2011 | MVIS | ↑ Buy | 5,000 | $0.91 | $5K | Direct | Aug 18, 2011 (0d) |
| Aug 8, 2011 | MVIS | ↑ Buy | 5,000 | $0.88 | $4K | Direct | Aug 8, 2011 (0d) |
| Jun 8, 2011 | MVIS | ↑ Buy | 10,000 | $1.13 | $11K | Direct | Jun 8, 2011 (0d) |
| Mar 3, 2011 | MVIS | ↑ Buy | 10,000 | $1.58 | $16K | Direct | Mar 4, 2011 (1d) |
| Mar 10, 2009 | MVIS | ↑ Buy | 5,000 | $0.86 | $4K | Direct | Mar 10, 2009 (0d) |
| Aug 21, 2008 | MVIS | ↑ Buy | 10,500 | $2.40 | $25K | Direct | Aug 21, 2008 (0d) |
| Aug 23, 2006 | MVIS | ↑ Buy | 3,000 | $1.32 | $4K | Direct | Aug 23, 2006 (0d) |
| Aug 9, 2006 | MVIS | ↑ Buy | 10,000 | $1.55 | $16K | Direct | Aug 9, 2006 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Alexander Y Tokman's insider trades
Alexander Y Tokman is Chief Executive Officer at ENDRA Life Sciences (NDRA). Since Aug 9, 2006, Alexander has reported 18 open-market purchases worth $251K and 1 sale worth $9K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (27 filings), shares withheld for taxes (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NDRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.